Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.

by Steffie K Naber, Suzette M Matthijsse, Kirsten Rozemeijer, Corine Penning, Inge M C M de Kok, Marjolein van Ballegooijen
Published 2016-01-01

Have preferences of girls changed almost 3 years after the much debated start of the HPV vaccination program in The Netherlands? A discrete choice experiment.

by Robine Hofman, Esther W de Bekker-Grob, Jan Hendrik Richardus, Harry J de Koning, Marjolein van Ballegooijen, Ida J Korfage
Published 2014-01-01

The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.

by Suzette M Matthijsse, Joost van Rosmalen, Jan A C Hontelez, Roel Bakker, Inge M C M de Kok, Marjolein van Ballegooijen, Sake J de Vlas
Published 2015-01-01

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.

by S Lucas Goede, Linda Rabeneck, Marjolein van Ballegooijen, Ann G Zauber, Lawrence F Paszat, Jeffrey S Hoch, Jean H E Yong, Sonja Kroep, Jill Tinmouth, Iris Lansdorp-Vogelaar
Published 2017-01-01

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.

by Suzette M Matthijsse, Steffie K Naber, Jan A C Hontelez, Roel Bakker, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Inge M C M de Kok, Harry J de Koning, Joost van Rosmalen, Sake J de Vlas
Published 2018-01-01